PŘEHLEDOVÉ ČLÁNKY Úspěšná léčba SAPHO syndromu (nebakteriální osteomyelitidy a akné) anakinrou a denosumabem. Popis případu a přehled léčebných možností E14 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék. 2023;69(5):E4-E14 / www.casopisvnitrnilekarstvi.cz LITERATURA 1. Benhamou CL, Chamot AM, Kahn MF, et al. Synovitis‑acne‑pustulosis hyperostosis ‑osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? Clin Exp Rheumatol. 1988;6(2):109-112. 2. Němec P. Revmatologie pro praxi. 2., přepracované a doplněné vydán. Praha: Grada Publishing, 2021;819 s 3. Rukavina I. SAPHO syndrome: a review. J Child Orthop. 2015;9(1):19-27. 4. Kishimoto M, Taniguchi Y, Tsuji S, et al. SAPHO syndrome and pustulotic arthro‑osteitis. 5. Girschick H, Finetti M, Orlando F, et al. The multifaceted presentation of chronic recurrent multifocal osteomyelitis: a series of 486 cases from the Eurofever international registry. Rheumatology. 2018;57(8):1504-1506. 6. Roy NBA, Zaal AI, Hall G, et al. Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra. Rheumatology. (Oxford) 2020;59(2):448-451. 7. Li C, Xiang Y, Wu X, Cao Y, et al. Serum IgG4 elevation in SAPHO syndrome: does it unmask a disease activity marker? Clin Exp Rheumatol. 2020;38(1):35-41. 8. Zhao Y, Sato TS, Nielsen SM, et al. Development of a scoring tool for chronic nonbacterial osteomyelitis magnetic resonance imaging and evaluation of its interrater reliability. J Rheumatol. 2020;47(5):739-747. 9. Korčáková E, Jeremiá P, Rčař J, et al. SAPHO - vzácná diagnóza. Česká radiologie. 2017;71(3):201-206. 10. Skotáková J, Červinková I, Šenkyř k J, et al. Význam MR vy etřen u diagnózy chronická rekurentn multifokáln osteomyelitida Česká radiologie. 2017;71(3):197-200. 11. Watanabe S, Sawa N, Mizuno H, et al. Bone histomorphometric and immunohistological analysis for hyperostosis in a patient with SAPHO syndrome: A case report. Bone Rep. 2020;13:100296. doi:10.1016/j.bonr.2020.100296 12. Kahn MS: Proriatic arthritis and synovitis, acne, pustulosis, hyperostosis et osteitis. Current Opinion in Rheumatology. 1993;5:428-435. 13. Hayem G. SAPHO syndrome. Rev Prat. 2004;54(15):1635-1636. 14. Bouchalová K, Fráňová J, Schüller M, et al. Chronická rekurentn multifokáln osteomyelitida (CRMO) v dětském věku – přehled a vlastn výsledky. Česká Revmatol. 2019;27(3):116-124. 15. Růžičková‑Jare ová L. Machovcová A. SAPHO syndrom. Dermatologie pro praxi. 2009;3(4):188-190. 16. Cheng W, Li F, Tian J, et al. New Insights in the Treatment of SAPHO Syndrome and Medication Recommendations. J Inflamm Res. 2022;15:2365-2380. 17. Otto S, Troeltzsch M, Burian E, et al. Ibandronate treatment of diffuse sclerosing osteomyelitis of the mandible: pain relief and insight into pathogenesis. J Craniomaxillofac Surg. 2015;43:1837-42. 18. Vekic DA, Woods J, Lin P, et al. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature. Int J Dermatol. 2018;57(1):10-18. 19. Vilar‑Alejo J, Dehesa L, de la Rosa‑del Rey P, et al. SAPHO syndrome with unusual cutaneous manifestations treated successfully with etanercept. Acta Derm Venereol. 2010;90(5):531-532. 20. Colina M, Pizzirani C, Khodeir M, et al. Dysregulation of P2X7 receptor‑inflammasome axis in SAPHO syndrome: successful treatment with anakinra. Rheumatology. 2010;49(7):1416-1418. 21. Daoussis D, Konstantopoulou G, Kraniotis P, et al. Biologics in SAPHO syndrome: a systematic review. Semin. Arthritis Rheum. 2019;48(4):618-625. 22. Pardeo M, Pires, S, Marafon D, et al. Anakinra in a cohort of children with chronic nonbacterial osteomyelitis. J. Rheumatol. 2017;44(8):1231-1238. 23. Maniscalco V, Abu‑Rumeileh S, Mastrolia MV, et al. The off‑label use of anakinra in pediatric systemic autoinflammatory diseases. Ther Adv Musculoskelet, DiS. 2020;12:1759720X20959575. doi:10.1177/1759720X20959575. 24. Firinu D, Garcia‑Larsen V. SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment. Curr Rheumatol Rep. 2016;18(6):35. doi: 10.1007/s11926-016-0583-y 25. Wendling D, Prati C, Aubin F. Anakinra treatment of SAPHO syndrome: short‑term results of an open study. Ann. Rheum, DiS. 2012;71(6):1098-1100. 26. Sun XC, Liu S, Li C, et al. Failure of tocilizumab in treating two patients with refractory SAPHO syndrome: a case report. J Int Med Res. 2018;46(12):5309-5315. 27. Sun B, Cao Y, Wang L, Wang M, Li C. Successful treatment of refractory mandibular lesions in SAPHO syndrome with secukinumab. Rheumatology (Oxford). 2021;60(1):473-474. 28. Wang L, Sun B, Li C. Clinical and radiological remission of osteoarticular and cutaneous lesions in SAPHO patients treated with secukinumab: a case series. J Rheumatol. 2021;48(6):953-955. 29. Cornillier H, Kervarrec T, Tabareau‑Delalande F, et al. Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol. 2016;26(6):614-615. 30. Yang Q, Zhao Y, Li C, et al. Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib. Medicine (Baltimore). 2018;97(25):e11149. 31. Li C, Li Z, Cao Y, et al. Tofacitinib for the treatment of nail lesions and palmoplantar pustulosis in synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome. JAMA Dermatol. 2021;157(1):74-78. 32. Adamo S, Nilsson J, Krebs A, et al. Successful treatment of SAPHO syndrome with apremilast. Br J Dermatol. 2018; 179(4):959-962. 33. Wang L, Gong L, Zhang X, et al. Tripterygium wilfordii Hook F. in the treatment of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a clinical trial. Clin Rheumatol. 2021;40(6):2427-2438. 34. Li C, Sun X, Cao Y,et al. Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment. Medicine (Baltimore). 2017;96(47):e8903. 35. Ščudla V, Horák P, Karásek D. Základy diferenciáln diagnostiky ve vnitřn m lékařstv 1. vydán . Olomouc: Univerzita Palackého v Olomouci, 2021. 679 stran. 36. Němec P, Řehák Z, Fabián P. Využit pozitronové emisn tomografie (18 F- FDG PET) v diagnostice chronických periaortitid. Vnitř Lék. 2008;54(11):1093-1099.
RkJQdWJsaXNoZXIy NDA4Mjc=